CNS Oncology

Edit Your Profile

CNS Oncology Journal

publication venue for

BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors. 6:95-99. 2017
Widely metastatic atypical pituitary adenoma with mTOR pathway STK11(F298L) mutation treated with everolimus therapy. 5:203-209. 2016
A Phase II trial of tandutinib (MLN 518) in combination with bevacizumab for patients with recurrent glioblastoma. 5:59-67. 2016
Prophylactic cranial irradiation: recent outcomes and innovations 2014

Electronic International Standard Serial Number (EISSN)

2045-0915